Revolutionizing drug formulation development: The increasing impact of machine learning

Z Bao, J Bufton, RJ Hickman, A Aspuru-Guzik… - Advanced Drug Delivery …, 2023 - Elsevier
Over the past few years, the adoption of machine learning (ML) techniques has rapidly
expanded across many fields of research including formulation science. At the same time …

Machine learning directed drug formulation development

P Bannigan, M Aldeghi, Z Bao, F Häse… - Advanced Drug Delivery …, 2021 - Elsevier
Abstract Machine learning (ML) has enabled ground-breaking advances in the healthcare
and pharmaceutical sectors, from improvements in cancer diagnosis, to the identification of …

[PDF][PDF] Self-driving laboratories: A paradigm shift in nanomedicine development

RJ Hickman, P Bannigan, Z Bao, A Aspuru-Guzik… - Matter, 2023 - cell.com
Nanomedicines have transformed promising therapeutic agents into clinically approved
medicines with optimal safety and efficacy profiles. This is exemplified by the mRNA …

Current status and future perspectives on MRNA drug manufacturing

C Webb, S Ip, NV Bathula, P Popova… - Molecular …, 2022 - ACS Publications
The coronavirus disease of 2019 (COVID-19) pandemic launched an unprecedented global
effort to rapidly develop vaccines to stem the spread of the novel severe acute respiratory …

Role of drug delivery technologies in the success of COVID-19 vaccines: a perspective

HI Labouta, R Langer, PR Cullis, OM Merkel… - Drug Delivery and …, 2022 - Springer
The triumphant success of mRNA vaccines is a testimony to the important role drug delivery
technologies have played in protecting billions of people against SARS-CoV-2 (or the …

AGILE platform: a deep learning-powered approach to accelerate LNP development for mRNA delivery

Y Xu, S Ma, H Cui, J Chen, S Xu, K Wang, A Varley… - bioRxiv, 2023 - biorxiv.org
Ionizable lipid nanoparticles (LNPs) have seen widespread use in mRNA delivery for clinical
applications, notably in SARS-CoV-2 mRNA vaccines. Despite their successful use …

Mechanistic studies of an automated lipid nanoparticle reveal critical pharmaceutical properties associated with enhanced mRNA functional delivery in vitro and in …

L Cui, MR Hunter, S Sonzini, S Pereira, SM Romanelli… - Small, 2022 - Wiley Online Library
Recently, lipid nanoparticles (LNPs) have attracted attention due to their emergent use for
COVID‐19 mRNA vaccines. The success of LNPs can be attributed to ionizable lipids, which …

Lipid nanoparticle delivery systems to enable mRNA-based therapeutics

SC Semple, R Leone, CJ Barbosa, YK Tam, PJC Lin - Pharmaceutics, 2022 - mdpi.com
The world raced to develop vaccines to protect against the rapid spread of SARS-CoV-2
infection upon the recognition of COVID-19 as a global pandemic. A broad spectrum of …

Non-liver mRNA delivery

D Loughrey, JE Dahlman - Accounts of chemical research, 2021 - ACS Publications
Conspectus mRNA drugs can preempt infectious disease and treat Mendelian disorders,
such as sickle cell anemia, muscular dystrophy, and cystic fibrosis, as well as autoimmunity …

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines

SJ Shepherd, X Han, AJ Mukalel… - Proceedings of the …, 2023 - National Acad Sciences
Lipid nanoparticles (LNPs) are a potent delivery technology that have made it possible for
the recent clinical breakthroughs in mRNA therapeutics and vaccines. A key challenge to the …